Table 2.
Prognostic-related 18-IRLPs signature by univariate Cox and LASSO regression analysis
| IRLPs | LncRNA1 | LncRNA2 | LASSO Coefficient | Univariate Cox HR | Univariate Cox P-value |
|---|---|---|---|---|---|
| LINC01082|MECOM-AS1 | LINC01082 | MECOM-AS1 | 0.182461199 | 1.844162 | 0.006239 |
| AL162231.2|AP000695.2 | AL162231.2 | AP000695.2 | − 0.090117905 | 0.604829 | 0.005055 |
| AF001548.1|MIR222HG | AF001548.1 | MIR222HG | 0.013909284 | 1.807629 | 0.001712 |
| AC092718.3|VPS9D1-AS1 | AC092718.3 | VPS9D1-AS1 | − 0.1216813 | 0.6087 | 0.009608 |
| AC092718.3|LBX2-AS1 | AC092718.3 | LBX2-AS1 | − 0.315792113 | 0.525771 | 0.000353 |
| AC018521.6|AP000695.2 | AC018521.6 | AP000695.2 | − 0.221816573 | 0.531631 | 0.000512 |
| AC010542.5|LINC01269 | AC010542.5 | LINC01269 | − 0.322756413 | 0.524657 | 0.000923 |
| LINC01232|AC015912.3 | LINC01232 | AC015912.3 | 0.227198005 | 1.719174 | 0.003078 |
| AC104695.2|AP000695.2 | AC104695.2 | AP000695.2 | − 0.120394541 | 0.525991 | 0.000775 |
| AL512274.1|AP005233.2 | AL512274.1 | AP005233.2 | − 0.223782758 | 0.606419 | 0.005118 |
| AL512274.1|LINC01023 | AL512274.1 | LINC01023 | − 0.035507173 | 0.603742 | 0.005325 |
| AL365181.3|AC016065.1 | AL365181.3 | AC016065.1 | − 0.036905121 | 0.600231 | 0.006761 |
| AL365181.3|AC133552.5 | AL365181.3 | AC133552.5 | − 0.13115007 | 0.538969 | 0.000808 |
| AP003071.4|AL133346.1 | AP003071.4 | AL133346.1 | 0.20335131 | 1.681189 | 0.006167 |
| AP003071.4|LINC02195 | AP003071.4 | LINC02195 | 0.210730199 | 1.649251 | 0.005243 |
| AC127521.1|AC005520.2 | AC127521.1 | AC005520.2 | − 0.153210626 | 0.560476 | 0.003205 |
| AL133346.1|AP000695.2 | AL133346.1 | AP000695.2 | − 0.196021258 | 0.615435 | 0.007012 |
| WASL-DT|LINC01023 | WASL-DT | LINC01023 | − 0.340532934 | 0.597772 | 0.004098 |
IRLPs immune-related lncRNA pairs, HR hazard ratio